205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.91%
Negative revenue growth while ON stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
6.12%
Gross profit growth under 50% of ON's 87.85%. Michael Burry would be concerned about a severe competitive disadvantage.
-72.73%
Negative EBIT growth while ON is at 138.01%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-72.73%
Negative operating income growth while ON is at 133.71%. Joel Greenblatt would press for urgent turnaround measures.
372.73%
Net income growth above 1.5x ON's 135.03%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
200.00%
EPS growth 1.25-1.5x ON's 135.65%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
200.00%
Diluted EPS growth 1.25-1.5x ON's 135.65%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.25%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.48%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.25%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
786.67%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
125.30%
Positive FCF growth while ON is negative. John Neff would see a strong competitive edge in net cash generation.
11.86%
10Y revenue/share CAGR under 50% of ON's 71.75%. Michael Burry would suspect a lasting competitive disadvantage.
-14.43%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-35.92%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
11.67%
5Y OCF/share CAGR at 50-75% of ON's 17.99%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-24.52%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-54.44%
Negative 10Y net income/share CAGR while ON is at 245.86%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-61.41%
Negative 5Y net income/share CAGR while ON is 12132.26%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-82.09%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
131.78%
5Y equity/share CAGR is in line with ON's 142.72%. Walter Schloss would see parallel mid-term profitability and retention policies.
60.37%
3Y equity/share CAGR 1.25-1.5x ON's 54.30%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
87.55%
Dividend/share CAGR of 87.55% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
14.29%
Dividend/share CAGR of 14.29% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.39%
3Y dividend/share CAGR of 37.39% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.10%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-9.02%
Inventory is declining while ON stands at 0.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.16%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.55%
We have a declining book value while ON shows 0.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.23%
We’re deleveraging while ON stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.71%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
25.55%
SG&A growth well above ON's 1.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.